Truist Securities Reiterates Buy on Ovintiv, Raises Price Target to $73

Benzinga Newsdesk www.benzinga.com Positive 84.8%

Neg 0% Neu 0% Pos 84.8%

Truist Securities analyst Gabe Daoud reiterates Ovintiv (NYSE:OVV) with a Buy and raises the price target from $66 to $73.